Achilles Therapeutics Plc buy BiotechBee
Start price
18.02.24
/
60%
€0.97
Target price
31.01.26
€2.00
Performance (%)
0.52%
End price
17.03.24
€0.98
Summary
This prediction ended on 17.03.24 with a price of €0.98. During the runtime of the prediction for Achilles Therapeutics Plc the price only changed by 0.52%. BiotechBee has a follow-up prediction for Achilles Therapeutics Plc where he still thinks Achilles Therapeutics Plc is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Achilles Therapeutics Plc | -2.632% | -2.632% |
iShares Core DAX® | -3.935% | -3.998% |
iShares Nasdaq 100 | -3.608% | -9.386% |
iShares Nikkei 225® | -4.513% | -8.017% |
iShares S&P 500 | -2.607% | -4.265% |
According to BiotechBee what are the pros and cons of Achilles Therapeutics Plc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Achilles Therapeutics Plc diskutieren
Buy mit Kursziel 2,0
In the thread Trading Achilles Therapeutics Plc
Buy beendet
Current prediction by BiotechBee for Achilles Therapeutics Plc
Achilles Therapeutics Plc
Start price
Target price
Perf. (%)
€0.98
17.03.24
17.03.24
€2.50
31.12.25
31.12.25
-28.21%
01.08.24
01.08.24
Could be very worthwhile Investment >20% year